700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02461

Synthetic patientMETA-24 · Day 139 · 55–64 · F · baseline S04Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
18%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S04
  2. Day 14 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • Inflammatory activity+6
  • Nutritional resilience-4
  • GI instability+3
  • Toxicity-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    75 min
    improving · +3.1 vs previous 14 d
    Sleep duration
    Wearable
    7.1 h
    stable · -0.0 vs previous 14 d
    Energy level
    Daily log
    6.4/10
    improving · +0.3 vs previous 14 d
    Steps
    Wearable
    8,289
    stable · -73 vs previous 14 d
    GI burden
    Companion
    22.3/100
    stable · -0.4 vs previous 14 d
    Adherence
    Companion
    95.2 %
    improving · +4.2 vs previous 14 d
    Sleep quality
    Wearable
    59.5/100
    worsening · -3.2 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    133 mg/dL
    stable · +2.4 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 68 from the failing basin, 23 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +5.4
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -3.5 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Low microbial diversity
      hidden · steering -7.7
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Dietary fat load
      perturbation · steering -5.5
    • Dietary fat load
      detractor · GI +3.3 next day
    • Simple carbohydrates
      detractor · GI +2.6 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -3.5supporter · 95%
    • Dietary fat load
      +3.3detractor · 95%
    • Simple carbohydrates
      +2.6detractor · 86%
    • Histamine load
      -1.9no signal · 45%
    • Ultra-processed food
      +1.4no signal · 51%
    • Insoluble fibre
      -0.4no signal · 15%
    • Caffeine
      +0.4no signal · 15%
    • Alcohol
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Butyrate / short-chain fatty acid production ↓60
      • MicrobiomeButyrate capacity 42/100
      • MicrobiomeF. prausnitzii depleted
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Inflammatory signalling ↑20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2 · butyrate capacity 42/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    54 ms
    Sleep
    7.3 h
    Steps
    8,468
    Resting HR
    70 bpm
    Daily log: GI score 22, nutritional resilience 61, adherence 95.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0214751%S13GI-04improved58
    P-0253850%S02GI-04improved59
    P-0223548%S14DT-01improved50
    P-0233948%S03DT-01improved50
    P-0264548%S02HY-01improved56
    P-0248447%S15GI-04improved49
    P-0203346%S06GI-04improved51
    P-0203746%S04GI-04improved53
    P-0269746%S07GI-04improved56
    P-0222344%S20HY-01improved49
    P-0227444%S15DT-01improved50
    P-0230344%S15GI-04improved48